Evidence map›Paper›PMID 37860961›Full record

ArticleActa crystallographica. Section D, Structural biology2023

The impact of molecular variants, crystallization conditions and the space group on ligand-protein complexes: a case study on bacterial phosphotriesterase.

Orly Dym, Nidhi Aggarwal, Yacov Ashani, Haim Leader, Shira Albeck, Tamar Unger, Shelly Hamer-Rogotner, Israel Silman, Dan S Tawfik, Joel L Sussman

Abstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Innovative Nanocarriers: Magnetosomes in the Fight against Cancer.Anti-cancer agents in medicinal chemistry · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Orly DymDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-4394-4971
Nidhi AggarwalDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Yacov AshaniDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-5555-9088
Haim LeaderDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Shira AlbeckDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-8520-7470
Tamar UngerDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-6418-7949
Shelly Hamer-RogotnerDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0009-0006-7228-9589
Israel SilmanDepartment of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-1923-0829
Dan S TawfikDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Joel L SussmanDepartment of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-0306-3878

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A bacterial phosphotriesterase was employed as an experimental paradigm to examine the effects of multiple factors, such as the molecular constructs, the ligands used during protein expression and purification, the crystallization conditions and the space group, on the visualization of molecular complexes of ligands with a target enzyme. In this case, the ligands used were organophosphates that are fragments of the nerve agents and insecticides on which the enzyme acts as a bioscavenger. 12 crystal structures of various phosphotriesterase constructs obtained by directed evolution were analyzed, with resolutions of up to 1.38 Å. Both apo forms and holo forms, complexed with the organophosphate ligands, were studied. Crystals obtained from three different crystallization conditions, crystallized in four space groups, with and without N-terminal tags, were utilized to investigate the impact of these factors on visualizing the organophosphate complexes of the enzyme. The study revealed that the tags used for protein expression can lodge in the active site and hinder ligand binding. Furthermore, the space group in which the protein crystallizes can significantly impact the visualization of bound ligands. It was also observed that the crystallization precipitants can compete with, and even preclude, ligand binding, leading to false positives or to the incorrect identification of lead drug candidates. One of the co-crystallization conditions enabled the definition of the spaces that accommodate the substituents attached to the P atom of several products of organophosphate substrates after detachment of the leaving group. The crystal structures of the complexes of phosphotriesterase with the organophosphate products reveal similar short interaction distances of the two partially charged O atoms of the P-O bonds with the exposed β-Zn

Indexed as

Phosphoric Triester HydrolasesCrystallizationCrystallography, X-RayLigandsOrganophosphatesReproducibility of ResultsLigandsOrganophosphatesPhosphoric Triester Hydrolasesbioscavengerscrystallization conditionsexpression systemsorganophosphatesphosphotriesterasesspace groupszinc ions

Identifiers

PMID37860961
PMCPMC10619419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.